HIGHLIGHTS
- who: Rolf Teschke from the Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, Frankfurt am Main, Germany have published the Article: Treatment of Drug-Induced Liver Injury, in the Journal: Biomedicines 2023, 11, 15. of /2023/
- what: With regrets, the study had limitations due to the randomized open-label trial study design , an avoidable shortcoming easily preventable if a prospective RCT study design is used in an upcoming study.
- how: In this article therapeutic options for patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.